Jinhong Zhu, Ph.D. - Publications

Affiliations: 
2009 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Biomedical Engineering, Molecular Biology

120 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Zhang X, Wang B, Lin L, Zhou C, Zhu J, Wu H, He J. gene rs828867 G>A polymorphism reduces neuroblastoma risk in Chinese children. Heliyon. 10: e27988. PMID 38509981 DOI: 10.1016/j.heliyon.2024.e27988  0.422
2023 Lin L, Wang B, Zhang X, Deng C, Zhou C, Zhu J, Wu H, He J. Functional TET2 gene polymorphisms increase the risk of neuroblastoma in Chinese children. Iubmb Life. PMID 38014648 DOI: 10.1002/iub.2791  0.459
2023 Ma L, Zhu J, Zhang J, Zhang W, Li Y, Yang Z, Li S, Cheng J, Li L, He J, Liu P. Identification of hepatoblastoma susceptibility loci in the TRMT6 gene from a seven-center case-control study. Journal of Cellular and Molecular Medicine. PMID 37850543 DOI: 10.1111/jcmm.18006  0.505
2023 Zeng D, Zhu J, Li J, Liao F, Yang Z, Li Y, Zhang J, Cheng J, Li S, Li L, He J. rs4563180 G>C variant reduces hepatoblastoma risk: a case-control study of seven medical centers. Aging. 15. PMID 37531210 DOI: 10.18632/aging.204926  0.457
2023 Chang X, Zhu J, Hua RX, Deng C, Zhang J, Cheng J, Li S, Zhou H, He J, Wang H. TRMT6 gene rs236110 C > A polymorphism increases the risk of Wilms tumor. Gene. 882: 147646. PMID 37473973 DOI: 10.1016/j.gene.2023.147646  0.497
2023 Deng L, Hua RX, Deng C, Zhu J, Zhang Z, Cheng J, Zhang J, Zhou H, Li S, Ruan J, Liu G, He J, Fu W. gene polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study. Journal of Cancer. 14: 1293-1300. PMID 37283791 DOI: 10.7150/jca.83747  0.502
2023 Deng L, Hua R, Zhang Z, Zhu J, Zhang J, Cheng J, Li S, Zhou H, Liu G, He J, Fu W. METTL1 gene polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study. Chinese Medical Journal. PMID 37232474 DOI: 10.1097/CM9.0000000000002739  0.336
2023 Zhu J, Liu X, Chen W, Liao Y, Liu J, Yuan L, Ruan J, He J. Association of RNA mG Modification Gene Polymorphisms with Pediatric Glioma Risk. Biomed Research International. 2023: 3678327. PMID 36733406 DOI: 10.1155/2023/3678327  0.487
2022 Lin L, Deng C, Zhou C, Zhang X, Zhu J, Liu J, Wu H, He J. NSUN2 gene rs13181449 C>T polymorphism reduces neuroblastoma risk. Gene. 854: 147120. PMID 36529349 DOI: 10.1016/j.gene.2022.147120  0.504
2022 He S, Zhu J, Xiao Z, Liu J, Zhang J, Li Y, Yang Z, Cheng J, Li S, Li L, He J, Xu D. gene polymorphisms increase hepatoblastoma susceptibility in girls. Journal of Cancer. 13: 3342-3347. PMID 36186903 DOI: 10.7150/jca.76255  0.502
2022 Liao F, Yuan L, Zhu J, Chen W, Zhao Y, He J. Association of rs1042522 C>G Polymorphism with Glioma Risk in Chinese Children. Biomed Research International. 2022: 2712808. PMID 35996546 DOI: 10.1155/2022/2712808  0.488
2021 Zeng H, Li M, Liu J, Zhu J, Cheng J, Li Y, Zhang J, Yang Z, Li L, Zhou H, Li S, Xia H, Zou Y, He J, Yang T. Gene rs3738067 A>G Polymorphism Decreases Neuroblastoma Risk in Chinese Children: Evidence From an Eight-Center Case-Control Study. Frontiers in Medicine. 8: 797195. PMID 34970571 DOI: 10.3389/fmed.2021.797195  0.472
2021 Chen H, Duan F, Wang M, Zhu J, Zhang J, Cheng J, Li L, Li S, Li Y, Yang Z, Xia H, Niu H, He J. Polymorphisms in METTL3 gene and hepatoblastoma risk in Chinese children: a seven-center case-control study. Gene. 145834. PMID 34274483 DOI: 10.1016/j.gene.2021.145834  0.504
2021 Lin A, Hua RX, Zhou M, Fu W, Zhang J, Zhou H, Li S, Cheng J, Zhu J, Xia H, Liu G, He J. YTHDC1 gene polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study. Gene. 145571. PMID 33737126 DOI: 10.1016/j.gene.2021.145571  0.446
2021 Zhou C, Wang Y, He L, Zhu J, Li J, Tang Y, Zhou H, He J, Wu H. Association between NER pathway gene polymorphisms and neuroblastoma risk in an eastern Chinese population. Molecular Therapy Oncolytics. 20: 3-11. PMID 33575466 DOI: 10.1016/j.omto.2020.12.004  0.474
2021 Yang Z, Deng Y, Zhang K, Bai Y, Zhu J, Zhang J, Cheng J, Li L, He J, Wang W. polymorphisms and hepatoblastoma susceptibility in Chinese children. Journal of Cancer. 12: 1373-1378. PMID 33531982 DOI: 10.7150/jca.52621  0.479
2020 Zhuo Z, Lu H, Zhu J, Hua RX, Li Y, Yang Z, Zhang J, Cheng J, Zhou H, Li S, Li L, Xia H, He J. METTL14 Gene Polymorphisms Confer Neuroblastoma Susceptibility: An Eight-Center Case-Control Study. Molecular Therapy. Nucleic Acids. 22: 17-26. PMID 32891980 DOI: 10.1016/J.Omtn.2020.08.009  0.566
2020 Pan J, Lin H, Yang T, Yang J, Hu C, Zhu J, Tan T, Li J, Xia H, He J, Zou Y. rs11752942 A>G polymorphism decreases neuroblastoma risk in Chinese children. Cell Cycle (Georgetown, Tex.). 1-6. PMID 32809919 DOI: 10.1080/15384101.2020.1808382  0.562
2020 Zhu J, Liu Y, Ao H, Liu M, Zhao M, Ma J. Comprehensive Analysis of the Immune Implication of Gene in Non-small Cell Lung Cancer. Frontiers in Oncology. 10: 1132. PMID 32793482 DOI: 10.3389/Fonc.2020.01132  0.329
2020 Zhuo Z, Zhou C, Fang Y, Zhu J, Lu H, Zhou H, Wu H, Wang Y, He J. Correlation between the genetic variants of base excision repair (BER) pathway genes and neuroblastoma susceptibility in eastern Chinese children. Cancer Communications (London, England). PMID 32780923 DOI: 10.1002/Cac2.12088  0.335
2020 Luo Z, Li G, Wang M, Zhu J, Yang Z, Li Y, Zhang J, Xin Y, Li S, Li L, Zhuo Z, He J. rs6090311 A>G polymorphism reduces Hepatoblastoma risk: Evidence from a seven-center case-control study. Journal of Cancer. 11: 5129-5134. PMID 32742460 DOI: 10.7150/Jca.46120  0.565
2020 Chen H, Li Y, Li L, Zhu J, Yang Z, Zhang J, Li S, Xin Y, Xia H, He J. YTHDC1 gene polymorphisms and hepatoblastoma susceptibility in Chinese children: A seven-center case-control study. The Journal of Gene Medicine. e3249. PMID 32729171 DOI: 10.1002/Jgm.3249  0.436
2020 Zhuo ZJ, Hua RX, Chen Z, Zhu J, Wang M, Yang Z, Zhang J, Li Y, Li L, Li S, Xin Y, Xia H, He J. Gene Variants Confer Hepatoblastoma Susceptibility: A Seven-Center Case-Control Study. Molecular Therapy Oncolytics. 18: 118-125. PMID 32671187 DOI: 10.1016/J.Omto.2020.06.007  0.578
2020 Bian J, Zhuo Z, Zhu J, Yang Z, Jiao Z, Li Y, Cheng J, Zhou H, Li S, Li L, He J, Liu Y. Association between METTL3 gene polymorphisms and neuroblastoma susceptibility: A nine-centre case-control study. Journal of Cellular and Molecular Medicine. PMID 32615646 DOI: 10.1111/Jcmm.15576  0.58
2020 Ma L, Hua RX, Lin H, Zhu J, Fu W, Lin A, Zhang J, Cheng J, Zhou H, Li S, Zhuo Z, He J. The contribution of WTAP gene variants to Wilms tumor susceptibility. Gene. 144839. PMID 32504654 DOI: 10.1016/J.Gene.2020.144839  0.535
2020 Fang Y, Wu X, Li L, Zhu J, Wu H, Zhou H, He J, Wang Y. TP53 Arg72Pro polymorphism and neuroblastoma susceptibility in eastern Chinese children: a three-center case-control study. Bioscience Reports. PMID 32406493 DOI: 10.1042/Bsr20200854  0.565
2020 Yang Z, Deng Y, Zhang K, Bai Y, Zhu J, Zhang J, Xin Y, Li L, He J, Wang W. gene polymorphisms modify hepatoblastoma susceptibility in Chinese children. Journal of Cancer. 11: 3512-3518. PMID 32284747 DOI: 10.7150/Jca.42798  0.582
2020 Pan J, Zhu J, Wang M, Yang T, Hu C, Yang J, Zhang J, Cheng J, Zhou H, Xia H, He J, Zou Y. Association of MYC gene polymorphisms with neuroblastoma risk in Chinese children: a four-center case-control study. The Journal of Gene Medicine. e3190. PMID 32222109 DOI: 10.1002/Jgm.3190  0.521
2020 Liu P, Zhuo ZJ, Zhu J, Yang Z, Xin Y, Li S, Li L, Li Y, Wang H, He J. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: a seven-center case-control study. The Journal of Gene Medicine. e3182. PMID 32166848 DOI: 10.1002/Jgm.3182  0.446
2020 Li L, Zhuo Z, Yang Z, Zhu J, He X, Yang Z, Zhang J, Xin Y, He J, Zhang T. Polymorphisms and Hepatoblastoma Susceptibility: A Five-Center Case-Control Study. Pharmacogenomics and Personalized Medicine. 13: 51-57. PMID 32104047 DOI: 10.2147/Pgpm.S241100  0.525
2020 Hua RX, Liu J, Fu W, Zhu J, Zhang J, Cheng J, Li S, Zhou H, Xia H, He J, Zhuo Z. ALKBH5 gene polymorphisms and Wilms tumor risk in Chinese children: A five-center case-control study. Journal of Clinical Laboratory Analysis. e23251. PMID 32091154 DOI: 10.1002/Jcla.23251  0.36
2020 Wang J, Lou S, Huang X, Mo Y, Wang Z, Zhu J, Tian X, Shi J, Zhou H, He J, Ruan J. The association of miR34b/c and TP53 gene polymorphisms with Wilms tumor risk in Chinese children. Bioscience Reports. PMID 32083300 DOI: 10.1042/Bsr20194202  0.544
2020 Liu J, Hua RX, Cheng Y, Zhu J, Zhang J, Cheng J, Zhou H, Xia H, Bian J, He J. Gene rs8756 A>C Polymorphism Reduces Neuroblastoma Risk in Chinese Children: A Four-Center Case-Control Study. Oncotargets and Therapy. 13: 465-472. PMID 32021290 DOI: 10.2147/Ott.S229975  0.542
2020 Huang X, Zhao J, Fu W, Zhu J, Lou S, Tian X, Chen S, Ruan J, He J, Zhou H. The association of and gene polymerphisms with Wilms tumor risk in Chinese children. Journal of Cancer. 11: 804-809. PMID 31949483 DOI: 10.7150/Jca.36651  0.557
2019 Hua RX, Zhuo Z, Ge L, Zhu J, Yuan L, Chen C, Liu J, Cheng J, Zhou H, Zhang J, Xia H, Zhang X, He J. LIN28A gene polymorphisms modify neuroblastoma susceptibility: A four-centre case-control study. Journal of Cellular and Molecular Medicine. PMID 31747721 DOI: 10.1111/Jcmm.14827  0.558
2019 Liu J, Hua RX, Fu W, Zhu J, Jia W, Zhang J, Zhou H, Cheng J, Xia H, Liu G, He J. gene associated polymorphisms and Wilms tumor risk in Chinese children: a four-center case-control study. Annals of Translational Medicine. 7: 475. PMID 31700911 DOI: 10.21037/Atm.2019.08.31  0.476
2019 Lin A, Fu W, Wang W, Zhu J, Liu J, Xia H, Liu G, He J. Association between PHOX2B gene rs28647582 T>C polymorphism and Wilms tumor susceptibility. Bioscience Reports. 39. PMID 31652452 DOI: 10.1042/Bsr20192529  0.536
2019 Lu T, Li L, Zhu J, Liu J, Lin A, Fu W, Liu G, Xia H, Zhang T, He J. rs8173 G>C Polymorphism Decreases Wilms Tumor Risk in Chinese Children. Journal of Oncology. 2019: 9074908. PMID 31636670 DOI: 10.1155/2019/9074908  0.571
2019 Lin A, Hua RX, Tang J, Zhu J, Zhang R, Zhou H, Zhang J, Cheng J, Xia H, He J. rs7973450 A>G increases neuroblastoma risk in Chinese children: a four-center case-control study. Oncotargets and Therapy. 12: 7289-7295. PMID 31564912 DOI: 10.2147/Ott.S223220  0.504
2019 Cheng J, Zhuo Z, Zhao P, Zhu J, Xin Y, Zhang J, Li P, Gao Y, He J, Zheng B. gene polymorphisms and neuroblastoma susceptibility in Chinese children. Journal of Cancer. 10: 4159-4164. PMID 31413734 DOI: 10.7150/Jca.34222  0.586
2019 Huang X, Zhao J, Zhu J, Chen S, Fu W, Tian X, Lou S, Ruan J, He J, Zhou H. MYCN gene polymorphisms and Wilms tumor susceptibility in Chinese children. Journal of Clinical Laboratory Analysis. e22988. PMID 31343784 DOI: 10.1002/Jcla.22988  0.4
2019 Liu J, Jia W, Hua RX, Zhu J, Zhang J, Yang T, Li P, Xia H, He J, Cheng J. Polymorphisms and Neuroblastoma Risk in Chinese Children: A Three-Center Case-Control Study. Oxidative Medicine and Cellular Longevity. 2019: 5736175. PMID 31341530 DOI: 10.1155/2019/5736175  0.578
2019 Zhuo Z, Fu W, Liu J, Cheng J, Zhou H, Zhang J, Zhu JH, Xia H, Liu G, He J. LIN28A gene polymorphisms confer Wilms tumour susceptibility: A four-centre case-control study. Journal of Cellular and Molecular Medicine. PMID 31338973 DOI: 10.1111/Jcmm.14561  0.559
2019 Li L, Zhu J, Lu T, Liu W, Tang J, Zhang J, Wang Y, Li Y, Li S, Zhou H, Xia H, He J, Cheng J. Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers. Translational Oncology. 12: 1282-1288. PMID 31325764 DOI: 10.1016/J.Tranon.2019.06.008  0.523
2019 Gao X, Jia W, Zhu J, Fu W, Zhu S, Xia H, He J, Liu G. Investigation of association between LINC00673 rs11655237 C>T and Wilms tumor susceptibility. Journal of Clinical Laboratory Analysis. e22930. PMID 31257678 DOI: 10.1002/Jcla.22930  0.506
2019 Li G, Jia W, Yin Z, Zhu J, Liu G, Xia H, He J, Fu W. Super-Enhancer rs2168101 G>T Polymorphism Reduces Wilms Tumor Risk. Journal of Cancer. 10: 1808-1813. PMID 31205537 DOI: 10.7150/Jca.29842  0.575
2019 Zhou C, Tang Y, Zhu J, He L, Li J, Wang Y, Zhou H, He J, Wu H. Association of miR-146a, miR-149 and miR-196a2 polymorphisms with neuroblastoma risk in Eastern Chinese population: a three-center case-control study. Bioscience Reports. PMID 31123171 DOI: 10.1042/Bsr20181907  0.43
2019 Jia W, Zhu J, Fu W, Zhu S, Deng F, Xia H, Liu GC, He J. Association of Gene Polymorphisms with Wilms' Tumor Susceptibility in Chinese Children. Journal of Oncology. 2019: 3518149. PMID 31057612 DOI: 10.1155/2019/3518149  0.544
2019 Hua RX, Zhuo Z, Zhu J, Zhang SD, Xue WQ, Li XZ, He J, Jia WH. LIG3 gene polymorphisms and risk of gastric cancer in a Southern Chinese population. Gene. PMID 31034940 DOI: 10.1016/J.Gene.2019.04.072  0.532
2019 Fu W, Zhuo Z, Hua RX, Fu K, Jia W, Zhu J, Zhang J, Cheng J, Zhou H, Xia H, He J, Liu G. Association of and gene polymorphisms with Wilms tumor risk: a four-center case-control study. Aging. PMID 30860980 DOI: 10.18632/aging.101855  0.472
2018 He L, Zhu J, Han F, Tang Y, Zhou C, Dai J, Wang Y, Zhou H, He J, Wu H. Gene Polymorphisms Reduce Neuroblastoma Risk in Eastern Chinese Children: A Three-Center Case-Control Study. Frontiers in Oncology. 8: 468. PMID 30406033 DOI: 10.3389/Fonc.2018.00468  0.575
2018 Zhang J, Zhuo Z, Li W, Zhu J, He J, Su J. gene polymorphisms and risk of neuroblastoma in Chinese children. Aging. PMID 30362960 DOI: 10.18632/aging.101601  0.477
2018 Zhu J, Fu W, Jia W, Xia H, Liu GC, He J. Association between NER Pathway Gene Polymorphisms and Wilms Tumor Risk. Molecular Therapy. Nucleic Acids. 12: 854-860. PMID 30161024 DOI: 10.1016/J.Omtn.2018.08.002  0.559
2018 Fu W, Li L, Xiong SW, Zhang T, Jia W, Zhu J, Zhao Z, Xia H, He J, Liu GC. rs6505162 C>A polymorphism contributes to decreased Wilms tumor risk. Journal of Cancer. 9: 2460-2465. PMID 30026843 DOI: 10.7150/Jca.24916  0.567
2018 Zhu J, Jia W, Wu C, Fu W, Xia H, Liu G, He J. Base Excision Repair Gene Polymorphisms and Wilms Tumor Susceptibility. Ebiomedicine. PMID 29937070 DOI: 10.1016/J.Ebiom.2018.06.018  0.546
2018 He J, Zou Y, Liu X, Zhu J, Zhang J, Zhang R, Yang T, Xia H. Association of Common Genetic Variants in Pre-microRNAs and Neuroblastoma Susceptibility: A Two-Center Study in Chinese Children. Molecular Therapy. Nucleic Acids. 11: 1-8. PMID 29858046 DOI: 10.1016/J.Omtn.2018.01.003  0.537
2018 Zhao J, Chen S, Zhou H, Zhang T, Liu Y, He J, Zhu J, Ruan J. rs17655 G>C polymorphism associated with cancer risk: evidence from 60 studies. Aging. PMID 29779017 DOI: 10.18632/aging.101448  0.437
2018 He J, Zhang X, Zhang J, Zhang R, Yang T, Zhu J, Xia H, Zou Y. super-enhancer polymorphism rs2168101 G>T correlates with decreased neuroblastoma risk in Chinese children. Journal of Cancer. 9: 1592-1597. PMID 29760797 DOI: 10.7150/Jca.24326  0.569
2018 Wang J, Zhuo Z, Chen M, Zhu J, Zhao J, Zhang J, Chen S, He J, Zhou H. polymorphisms and neuroblastoma risk in Chinese children: a three-center case-control study. Aging. PMID 29706609 DOI: 10.18632/aging.101429  0.493
2018 He J, Zhuo ZJ, Zhang A, Zhu J, Hua RX, Xue WQ, Zhang SD, Zhang JB, Li XZ, Jia WH. Genetic variants in the nucleotide excision repair pathway genes and gastric cancer susceptibility in a southern Chinese population. Cancer Management and Research. 10: 765-774. PMID 29695933 DOI: 10.2147/Cmar.S160080  0.427
2018 Tang J, Qian Y, Zhu J, Zhang J, Wang FH, Zeng JH, Liang JH, Wang H, Xia H, He J, Liu W. Lack of associations between AURKA gene polymorphisms and neuroblastoma susceptibility in Chinese children. Bioscience Reports. PMID 29678897 DOI: 10.1042/Bsr20180292  0.552
2018 Tang J, Liu W, Zhu J, Zhang J, Wang FH, Liang JH, Zeng JH, Wang H, Xia H, He J. RSRC1 and CPZ gene polymorphisms with neuroblastoma susceptibility in Chinese children. Gene. PMID 29653227 DOI: 10.1016/J.Gene.2018.04.015  0.55
2018 Zhuo ZJ, Zhang R, Zhang J, Zhu J, Yang T, Zou Y, He J, Xia H. Associations between lncRNApolymorphisms and neuroblastoma risk in Chinese children. Aging. 10: 481-491. PMID 29615542 DOI: 10.18632/aging.101406  0.449
2018 Zhuo ZJ, Liu W, Zhang J, Zhu J, Zhang R, Tang J, Yang T, Zou Y, He J, Xia H. Functional Polymorphisms at ERCC1/XPF Genes Confer Neuroblastoma Risk in Chinese Children. Ebiomedicine. PMID 29544698 DOI: 10.1016/J.Ebiom.2018.03.003  0.555
2018 Wu Q, Zhuo ZJ, Zeng J, Zhang J, Zhu J, Zou Y, Zhang R, Yang T, Zhu D, He J, Xia H. Association betweenGene Polymorphisms and Neuroblastoma Risk in Chinese Children: A Two-Center Case-Control Study. Journal of Cancer. 9: 535-539. PMID 29483959 DOI: 10.7150/Jca.22681  0.567
2018 Zhang Z, Chang Y, Jia W, Zhang J, Zhang R, Zhu J, Yang T, Xia H, Zou Y, He J. LINC00673 rs11655237 C>T confers neuroblastoma susceptibility in Chinese population. Bioscience Reports. PMID 29339420 DOI: 10.1042/Bsr20171667  0.542
2017 Jia W, Deng Z, Zhu J, Fu W, Zhu S, Zhang LY, Hu J, Wang F, Xia H, Liu GC, He J. Association Between HACE1 Gene Polymorphisms and Wilms' Tumor Risk in a Chinese Population. Cancer Investigation. 35: 633-638. PMID 29243987 DOI: 10.1080/07357907.2017.1405016  0.496
2017 He J, Zou Y, Wang T, Zhang R, Yang T, Zhu J, Wang F, Xia H. Genetic Variations of GWAS-Identified Genes and Neuroblastoma Susceptibility: a Replication Study in Southern Chinese Children. Translational Oncology. 10: 936-941. PMID 29024823 DOI: 10.1016/J.Tranon.2017.09.008  0.573
2017 Zhou H, Shi TY, Zhang W, Li Q, Zhu J, He J, Ruan J. XPG gene rs751402 C>T polymorphism and cancer risk: Evidence from 22 publications. Oncotarget. 8: 53613-53622. PMID 28881835 DOI: 10.18632/Oncotarget.19421  0.551
2017 Liu GC, Zhuo ZJ, Zhu SB, Zhu J, Jia W, Zhao Z, Hu JH, He J, Wang FH, Fu W. Associations between LMO1 gene polymorphisms and Wilms' tumor susceptibility. Oncotarget. 8: 50665-50672. PMID 28881592 DOI: 10.18632/Oncotarget.16926  0.562
2017 Han C, Huang X, Hua R, Song S, Lyu L, Ta N, Zhu J, Zhang P. The association between XPG polymorphisms and cancer susceptibility: Evidence from observational studies. Medicine. 96: e7467. PMID 28796034 DOI: 10.1097/MD.0000000000007467  0.432
2017 Hua W, Zhang A, Duan P, Zhu J, Zhao Y, He J, Zhang Z. MDM2 promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjects. Oncotargets and Therapy. 10: 3773-3780. PMID 28794641 DOI: 10.2147/Ott.S140424  0.553
2017 Zhou H, Shi TY, Zhang W, Li Q, Zhu J, He J, Ruan J. XPG gene rs751402 C>T polymorphism and cancer risk: Evidence from 22 publications. Oncotarget. PMID 28743838 DOI: 10.18632/oncotarget.19421  0.47
2017 Xiong SW, Ma J, Feng F, Fu W, Shu SR, Ma T, Wu C, Liu GC, Zhu J. Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis. Oncotarget. 8: 25300-25309. PMID 28445975 DOI: 10.18632/Oncotarget.15811  0.544
2017 Liu GC, Zhuo ZJ, Zhu SB, Zhu J, Jia W, Zhao Z, Hu JH, He J, Wang FH, Fu W. Associations between LMO1 gene polymorphisms and Wilms' tumor susceptibility. Oncotarget. PMID 28445865 DOI: 10.18632/oncotarget.16926  0.484
2017 Zhang Z, Zou Y, Zhu J, Zhang R, Yang T, Wang F, Xia H, He J, Feng Z. HSD17B12 gene rs11037575 C>T polymorphism confers neuroblastoma susceptibility in a Southern Chinese population. Oncotargets and Therapy. 10: 1969-1975. PMID 28435286 DOI: 10.2147/Ott.S136006  0.58
2017 Huang J, Liu X, Tang LL, Long JT, Zhu J, Hua RX, Li J. XPG gene polymorphisms and cancer susceptibility: evidence from 47 studies. Oncotarget. PMID 28416771 DOI: 10.18632/Oncotarget.16146  0.558
2017 Fu W, Liu GC, Zhao Z, Zhu J, Jia W, Zhu SB, Hu JH, Wang FH, He J, Xia H. The correlation between LIN28B gene potentially functional variants and Wilms tumor susceptibility in Chinese children. Journal of Clinical Laboratory Analysis. PMID 28301057 DOI: 10.1002/Jcla.22200  0.363
2017 He J, Wang F, Zhu J, Zhang Z, Zou Y, Zhang R, Yang T, Xia H. The TP53 gene rs1042522 C>G polymorphism and neuroblastoma risk in Chinese children. Aging. PMID 28275206 DOI: 10.18632/aging.101196  0.506
2017 Fu W, Zhuo ZJ, Jia W, Zhu J, Zhu SB, Lin ZF, Wang FH, Xia H, He J, Liu GC. Association between TP53 gene Arg72Pro polymorphism and Wilms' tumor risk in a Chinese population. Oncotargets and Therapy. 10: 1149-1154. PMID 28260929 DOI: 10.2147/Ott.S131014  0.547
2017 Zhang Z, Zhang R, Zhu J, Wang F, Yang T, Zou Y, He J, Xia H. Common variations within HACE1 gene and neuroblastoma susceptibility in a Southern Chinese population. Oncotargets and Therapy. 10: 703-709. PMID 28223827 DOI: 10.2147/Ott.S129042  0.574
2017 Fu W, Zhu J, Xiong SW, Jia W, Zhao Z, Zhu SB, Hu JH, Wang FH, Xia H, He J, Liu GC. BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility. Ebiomedicine. PMID 28161399 DOI: 10.1016/J.Ebiom.2017.01.038  0.568
2016 Fu W, Zhuo ZJ, Chen YC, Zhu J, Zhao Z, Jia W, Hu JH, Fu K, Zhu SB, He J, Liu GC. NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies. Oncotarget. PMID 28039461 DOI: 10.18632/Oncotarget.14190  0.486
2016 Hua RX, Zhuo ZJ, Zhu J, Jiang DH, Xue WQ, Zhang SD, Zhang JB, Li XZ, Zhang PF, Jia WH, Shen GP, He J. Association between genetic variants in the XPG gene and gastric cancer risk in a Southern Chinese population. Aging. PMID 27929383 DOI: 10.18632/aging.101119  0.416
2016 Zhu J, Ma J, Wang X, Ma T, Zhang S, Wang W, Zhou X, Shi J. High Expression of PHGDH Predicts Poor Prognosis in Non-Small Cell Lung Cancer. Translational Oncology. 9: 592-599. PMID 27916294 DOI: 10.1016/J.Tranon.2016.08.003  0.314
2016 Zheng J, Zhang R, Zhu J, Wang F, Yang T, He J, Xia H. Lack of Associations between XPC Gene Polymorphisms and Neuroblastoma Susceptibility in a Chinese Population. Biomed Research International. 2016: 2932049. PMID 27847809 DOI: 10.1155/2016/2932049  0.573
2016 Hua RX, Zhuo ZJ, Zhu J, Zhang SD, Xue WQ, Zhang JB, Xu HM, Li XZ, Zhang PF, He J, Jia WH. XPG Gene Polymorphisms Contribute to Colorectal Cancer Susceptibility: A Two-Stage Case-Control Study. Journal of Cancer. 7: 1731-1739. PMID 27698911 DOI: 10.7150/Jca.15602  0.553
2016 Xu C, Zhu J, Fu W, Liang Z, Song S, Zhao Y, Lyu L, Zhang A, He J, Duan P. MDM4 rs4245739 A > C polymorphism correlates with reduced overall cancer risk in a meta-analysis of 69477 subjects. Oncotarget. PMID 27687591 DOI: 10.18632/Oncotarget.12326  0.571
2016 Hua RX, Zhu J, Jiang DH, Zhang SD, Zhang JB, Xue WQ, Li XZ, Zhang PF, He J, Jia WH. Association of XPC Gene Polymorphisms with Colorectal Cancer Risk in a Southern Chinese Population: A Case-Control Study and Meta-Analysis. Genes. 7. PMID 27669310 DOI: 10.3390/Genes7100073  0.563
2016 Hua RX, Zhuo ZJ, Shen GP, Zhu J, Zhang SD, Xue WQ, Li XZ, Zhang PF, He J, Jia WH. Polymorphisms in the XPC gene and gastric cancer susceptibility in a Southern Chinese population. Oncotargets and Therapy. 9: 5513-9. PMID 27660469 DOI: 10.2147/Ott.S113055  0.533
2016 Jia XQ, Zhang S, Zhu HJ, Wang W, Zhu JH, Wang XD, Qiang JF. Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer. Translational Oncology. 9: 191-196. PMID 27267836 DOI: 10.1016/J.Tranon.2016.03.006  0.339
2016 He J, Yang T, Zhang R, Zhu J, Wang F, Zou Y, Xia H. Potentially functional polymorphisms in the LIN28B gene contribute to neuroblastoma susceptibility in Chinese children. Journal of Cellular and Molecular Medicine. PMID 27021521 DOI: 10.1111/Jcmm.12846  0.585
2016 He J, Wang F, Zhu J, Zhang R, Yang T, Zou Y, Xia H. Association of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese population. Journal of Cellular and Molecular Medicine. PMID 27019310 DOI: 10.1111/Jcmm.12836  0.569
2016 He J, Zhong W, Zeng J, Zhu J, Zhang R, Wang F, Yang T, Zou Y, Xia H. LMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population. Oncotarget. PMID 27009839 DOI: 10.18632/Oncotarget.8178  0.566
2016 Zhang R, Zou Y, Zhu J, Zeng X, Yang T, Wang F, He J, Xia H. The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population. International Journal of Medical Sciences. 13: 133-8. PMID 26941572 DOI: 10.7150/Ijms.13426  0.559
2016 Wang F, Zhang SD, Xu HM, Zhu JH, Hua RX, Xue WQ, Li XZ, Wang TM, He J, Jia WH. XPG rs2296147 T>C polymorphism predicted clinical outcome in colorectal cancer. Oncotarget. PMID 26887052 DOI: 10.18632/oncotarget.7352  0.461
2016 Zhu J, Wang M, He J, Zhu M, Wang JC, Jin L, Wang XF, Yang YJ, Xiang JQ, Wei Q. Polymorphisms in the AKT1 and AKT2 genes and oesophageal squamous cell carcinoma risk in an Eastern Chinese population. Journal of Cellular and Molecular Medicine. PMID 26828791 DOI: 10.1111/Jcmm.12750  0.559
2016 Huang X, Gao Y, He J, Cai J, Ta N, Jiang H, Zhu J, Zheng J. The association between RFC1 G80A polymorphism and cancer susceptibility: Evidence from 33 studies. Journal of Cancer. 7: 144-52. PMID 26819637 DOI: 10.7150/Jca.13303  0.447
2015 He J, Zhang R, Zou Y, Zhu J, Yang T, Wang F, Xia H. Evaluation of GWAS-identified SNPs at 6p22 with neuroblastoma susceptibility in a Chinese population. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26307394 DOI: 10.1007/S13277-015-3936-7  0.547
2015 Zhang T, Xie S, Zhu JH, Li QW, He J, Zeng AP. Association of IL10 -819C>T and -592C>A Polymorphisms with Non-Hodgkin Lymphoma Susceptibility: Evidence from Published Studies. Journal of Cancer. 6: 709-716. PMID 26185532 DOI: 10.7150/Jca.11745  0.461
2015 Li Q, Liu X, Hua RX, Wang F, An H, Zhang W, Zhu JH. Association of three 8q24 polymorphisms with prostate cancer susceptibility: evidence from a meta-analysis with 50,854 subjects. Scientific Reports. 5: 12069. PMID 26159557 DOI: 10.1038/Srep12069  0.539
2015 Gu Y, Dai QS, Hua RX, Zhang B, Zhu JH, Huang JW, Xie BH, Xiong SQ, Tan GS, Li HP. PSCA s2294008 C>T and rs2976392 G>A polymorphisms contribute to cancer susceptibility: evidence from published studies. Genes & Cancer. 6: 254-64. PMID 26124924 DOI: 10.18632/Genesandcancer.63  0.554
2015 Zhang Y, Xia ZG, Zhu JH, Chen MB, Wang TM, Shen WX, He J. Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis. Molecular Genetics and Genomics : Mgg. PMID 25977148 DOI: 10.1007/S00438-015-1058-Y  0.443
2015 Chen S, Zhu JH, Wang F, Huang SY, Xue WQ, Cui Z, He J, Jia WH. Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin's lymphoma: evidence from a meta-analysis. Chinese Journal of Cancer. 34: 108-14. PMID 25962431 DOI: 10.1186/S40880-015-0001-2  0.508
2015 Zhu J, Wang M, Zhu M, He J, Wang JC, Jin L, Wang XF, Xiang JQ, Wei Q. Associations of PI3KR1 and mTOR polymorphisms with esophageal squamous cell carcinoma risk and gene-environment interactions in Eastern Chinese populations. Scientific Reports. 5: 8250. PMID 25654238 DOI: 10.1038/Srep08250  0.507
2015 Zhang Y, Yang D, Zhu JH, Chen MB, Shen WX, He J. The association between NQO1 Pro187Ser polymorphism and urinary system cancer susceptibility: a meta-analysis of 22 studies. Cancer Investigation. 33: 39-40. PMID 25608636 DOI: 10.3109/07357907.2014.998836  0.469
2015 Yang S, Jin T, Su HX, Zhu JH, Wang DW, Zhu SJ, Li S, He J, Chen YH. The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analysis of 15 studies. Plos One. 10: e0116500. PMID 25602258 DOI: 10.1371/Journal.Pone.0116500  0.47
2014 Xue WQ, He YQ, Zhu JH, Ma JQ, He J, Jia WH. Association of BRCA2 N372H polymorphism with cancer susceptibility: a comprehensive review and meta-analysis. Scientific Reports. 4: 6791. PMID 25348552 DOI: 10.1038/srep06791  0.384
2014 He YQ, Zhu JH, Huang SY, Cui Z, He J, Jia WH. The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 12509-17. PMID 25204673 DOI: 10.1007/s13277-014-2569-6  0.383
2014 He J, Wang F, Zhu JH, Chen W, Cui Z, Jia WH. No association between MTR rs1805087 A > G polymorphism and non-Hodgkin lymphoma susceptibility: evidence from 11 486 subjects. Leukemia & Lymphoma. 56: 763-7. PMID 24956146 DOI: 10.3109/10428194.2014.935370  0.438
2014 Zhu J, Hua RX, Jiang J, Zhao LQ, Sun X, Luan J, Lang Y, Sun Y, Shang K, Peng S, Ma J. Association studies of ERCC1 polymorphisms with lung cancer susceptibility: a systematic review and meta-analysis. Plos One. 9: e97616. PMID 24841208 DOI: 10.1371/Journal.Pone.0097616  0.548
2014 Hua RX, Li HP, Liang YB, Zhu JH, Zhang B, Ye S, Dai QS, Xiong SQ, Gu Y, Sun XZ. Association between the PARP1 Val762Ala polymorphism and cancer risk: evidence from 43 studies. Plos One. 9: e87057. PMID 24489833 DOI: 10.1371/Journal.Pone.0087057  0.52
2014 Li S, Dai Q, Chen S, Zhang S, Liao X, Deng X, Chi H, Li F, Zhu J, Jiang Y. Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis. Tumor Biology. 35: 3905-3915. PMID 24347488 DOI: 10.1007/S13277-013-1519-Z  0.564
2014 Yin ZB, Hua RX, Li JH, Sun C, Zhu JH, Su X, Ji C, Xiang Q, Hua ZM. Smoking and hOGG1 Ser326Cys polymorphism contribute to lung cancer risk: evidence from a meta-analysis. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 1609-18. PMID 24085357 DOI: 10.1007/S13277-013-1222-0  0.495
2011 Zhu J, Li Y, Lu A, Gharaibeh B, Ma J, Kobayashi T, Quintero AJ, Huard J. Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. The American Journal of Pathology. 179: 915-30. PMID 21689628 DOI: 10.1016/J.Ajpath.2011.04.008  0.458
2008 Nozaki M, Li Y, Zhu J, Ambrosio F, Uehara K, Fu FH, Huard J. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. The American Journal of Sports Medicine. 36: 2354-62. PMID 18725651 DOI: 10.1177/0363546508322886  0.456
2008 Shen W, Li Y, Zhu J, Schwendener R, Huard J. Interaction between macrophages, TGF-beta1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury. Journal of Cellular Physiology. 214: 405-12. PMID 17657727 DOI: 10.1002/Jcp.21212  0.457
2007 Li Y, Li J, Zhu J, Sun B, Branca M, Tang Y, Foster W, Xiao X, Huard J. Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1616-22. PMID 17609657 DOI: 10.1038/Sj.Mt.6300250  0.417
2007 Zhu J, Li Y, Shen W, Qiao C, Ambrosio F, Lavasani M, Nozaki M, Branca MF, Huard J. Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. The Journal of Biological Chemistry. 282: 25852-63. PMID 17597062 DOI: 10.1074/Jbc.M704146200  0.64
2006 Zhu J, Li Y, Qiao C, Xiao X, Huard J. 1065. AAV2 Vector-Delivered Myostatin Propeptide Improves Muscle Healing after Injury Molecular Therapy. 13: S408-S409. DOI: 10.1016/J.Ymthe.2006.08.1163  0.405
Show low-probability matches.